Orchestra Biomed Hldgs Inc (OBIO)

$4.19 -0.11 (-2.56%)
Market Cap 250.90M
Revenue (ttm) 33.48M
Net Income (ttm) -52.70M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -157.41%
Debt to Equity Ratio 0.35
Volume 252,800
Avg Vol 360,992
Day's Range N/A - N/A
Shares Out 59.88M
Stochastic %K 36%
Beta 0.49
Analysts Strong Sell
Price Target $12.29

Company Profile

Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States. The company's flagship product candidates include Atrioventricular Interval Modulation, a bioelectronic therapy candidate designed to immediately, substantially, and persistently lower blood pressure; and Virtue Sirolimus AngioInfusion Balloon for the treatment of atherosclerotic artery disease. It also develops Cardiac Neuromodulation Therapy for heart failure, or potential treatment of clinical indications,...

Industry: Biotechnology
Sector: Healthcare
Phone: 215 862 5797
Address:
150 Union Square Drive, New Hope, United States
JHisai
JHisai Jul. 1 at 10:10 AM
$OBIO monthly
0 · Reply
JHisai
JHisai Jun. 30 at 7:24 PM
$OBIO -9% and yesterdays gains almost gone, now that s.cks
0 · Reply
JHisai
JHisai Jun. 29 at 8:03 PM
$OBIO
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Jun. 29 at 5:15 PM
$OBIO Added so clearly u didn't have to decipher my message. U should have made easy money here 💬
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Jun. 29 at 4:38 PM
$OBIO There it is $4.39 high.. Super day on this overnight swing winner 🥇 🥇
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Jun. 29 at 3:11 PM
$OBIO Adds are beautiful.. Now has to break $4.30 ✅✅
0 · Reply
JHisai
JHisai Jun. 29 at 2:28 PM
$OBIO
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Jun. 29 at 1:39 PM
$OBIO Adds!
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Jun. 29 at 3:52 AM
$OBIO Needs to break $4.24 for a shot at $5.00🚨🚨
0 · Reply
focafoca99
focafoca99 Jun. 23 at 9:02 PM
$OBIO held its 2026 annual meeting, with shareholders electing directors and approving the auditor, ESPP and compensation advisory
0 · Reply
Latest News on OBIO
Orchestra BioMed joins Russell 3000, Russell 2000 Indexes

2026-06-29T12:16:49.000Z - 5 days ago

Orchestra BioMed joins Russell 3000, Russell 2000 Indexes

Orchestra BioMed Joins Russell 3000® and Russell 2000® Indexes

Jun 29, 2026, 8:00 AM EDT - 5 days ago

Orchestra BioMed Joins Russell 3000® and Russell 2000® Indexes

Orchestra BioMed Holdings Transcript: AGM 2026

Jun 23, 2026, 12:00 PM EDT - 11 days ago

Orchestra BioMed Holdings Transcript: AGM 2026

Orchestra BioMed Holdings Transcript: Sidoti Small-Cap Virtual Investor Conference

Jun 18, 2026, 1:00 PM EDT - 16 days ago

Orchestra BioMed Holdings Transcript: Sidoti Small-Cap Virtual Investor Conference

Orchestra BioMed Holdings Proxy statement: Proxy filing

Jun 16, 2026, 8:00 AM EDT - 18 days ago

Orchestra BioMed Holdings Proxy statement: Proxy filing

Orchestra BioMed Holdings Transcript: Jefferies Global Healthcare Conference 2026

Jun 4, 2026, 9:55 AM EDT - 4 weeks ago

Orchestra BioMed Holdings Transcript: Jefferies Global Healthcare Conference 2026

Orchestra BioMed Holdings Slides: Corporate presentation

Jun 4, 2026, 7:00 AM EDT - 4 weeks ago

Orchestra BioMed Holdings Slides: Corporate presentation

Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Jun 2, 2026, 4:05 PM EDT - 4 weeks ago

Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Orchestra BioMed price target lowered to $10 from $12 at B. Riley

2026-05-19T12:40:53.000Z - 6 weeks ago

Orchestra BioMed price target lowered to $10 from $12 at B. Riley

Orchestra BioMed to Participate in the Jefferies Global Healthcare Conference

May 19, 2026, 8:30 AM EDT - 6 weeks ago

Orchestra BioMed to Participate in the Jefferies Global Healthcare Conference

Orchestra BioMed price target raised to $13 from $12 at Barclays

2026-05-13T09:15:10.000Z - 7 weeks ago

Orchestra BioMed price target raised to $13 from $12 at Barclays

Orchestra BioMed reports Q1 EPS (33c), consensus (44c)

2026-05-12T21:08:53.000Z - 7 weeks ago

Orchestra BioMed reports Q1 EPS (33c), consensus (44c)

Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates

May 12, 2026, 4:18 PM EDT - 7 weeks ago

Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates

Orchestra BioMed gives clinical, regulatory update on BACKBEAT trial timeline

2026-05-12T14:08:39.000Z - 7 weeks ago

Orchestra BioMed gives clinical, regulatory update on BACKBEAT trial timeline

MDT

Orchestra BioMed Targeting BACKBEAT Trial Enrollment Completion By End of Q3 2026 and Data Presentation in Q2 2027

May 12, 2026, 8:30 AM EDT - 7 weeks ago

Orchestra BioMed Targeting BACKBEAT Trial Enrollment Completion By End of Q3 2026 and Data Presentation in Q2 2027

Orchestra BioMed Holdings Quarterly report: Q1 2026

May 12, 2026, 7:00 AM EDT - 7 weeks ago

Orchestra BioMed Holdings Quarterly report: Q1 2026

Orchestra BioMed Holdings Earnings release: Q1 2026

May 12, 2026, 7:00 AM EDT - 7 weeks ago

Orchestra BioMed Holdings Earnings release: Q1 2026

Orchestra BioMed receives $15M payment from Ligand

2026-05-07T05:00:15.000Z - 2 months ago

Orchestra BioMed receives $15M payment from Ligand

LGND

Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement

May 6, 2026, 8:01 AM EDT - 2 months ago

Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement

Orchestra BioMed Receives $20 Million Payment from Medtronic Under Previously Announced Financing Agreement

May 6, 2026, 8:00 AM EDT - 2 months ago

Orchestra BioMed Receives $20 Million Payment from Medtronic Under Previously Announced Financing Agreement

MDT

Orchestra granted additional breakthrough device designation for AVIM therapy

2026-04-30T19:15:18.000Z - 2 months ago

Orchestra granted additional breakthrough device designation for AVIM therapy

MDT

FDA Grants Orchestra BioMed Additional Breakthrough Device Designation for AVIM Therapy

Apr 30, 2026, 9:00 AM EDT - 2 months ago

FDA Grants Orchestra BioMed Additional Breakthrough Device Designation for AVIM Therapy

MDT

Orchestra BioMed Holdings Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 2 months ago

Orchestra BioMed Holdings Proxy statement: Proxy filing

Orchestra BioMed Holdings Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 2 months ago

Orchestra BioMed Holdings Proxy statement: Proxy filing

Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026

Apr 23, 2026, 12:00 PM EDT - 2 months ago

Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026

Orchestra BioMed Holdings Slides: Corporate presentation

Apr 1, 2026, 7:00 AM EDT - 3 months ago

Orchestra BioMed Holdings Slides: Corporate presentation

Orchestra BioMed reports FY25 EPS ($1.11), consensus ($1.74)

2026-03-12T12:28:04.000Z - 4 months ago

Orchestra BioMed reports FY25 EPS ($1.11), consensus ($1.74)

Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update

Mar 12, 2026, 8:17 AM EDT - 4 months ago

Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update

Orchestra BioMed Holdings Earnings release: Q4 2025

Mar 12, 2026, 7:00 AM EDT - 4 months ago

Orchestra BioMed Holdings Earnings release: Q4 2025

Orchestra BioMed Holdings Annual report: Q4 2025

Mar 12, 2026, 7:00 AM EDT - 4 months ago

Orchestra BioMed Holdings Annual report: Q4 2025

Orchestra BioMed Holdings Transcript: Barclays 28th Annual Global Healthcare Conference

Mar 11, 2026, 8:00 AM EDT - 4 months ago

Orchestra BioMed Holdings Transcript: Barclays 28th Annual Global Healthcare Conference

Orchestra BioMed Holdings Transcript: TD Cowen 46th Annual Health Care Conference

Mar 3, 2026, 9:50 AM EST - 4 months ago

Orchestra BioMed Holdings Transcript: TD Cowen 46th Annual Health Care Conference

Orchestra BioMed announces two presentations at THT, CRT 2026 meetings

2026-03-03T13:22:43.000Z - 4 months ago

Orchestra BioMed announces two presentations at THT, CRT 2026 meetings

Orchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at THT and CRT

Mar 3, 2026, 8:00 AM EST - 4 months ago

Orchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at THT and CRT

Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences

Feb 19, 2026, 8:00 AM EST - 4 months ago

Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences

Orchestra BioMed Holdings Slides: Corporate presentation

Feb 18, 2026, 7:00 AM EST - 4 months ago

Orchestra BioMed Holdings Slides: Corporate presentation

Orchestra BioMed to receive up to $21M in proceeds from Vivasure acquisition

2026-01-12T14:11:12.000Z - 6 months ago

Orchestra BioMed to receive up to $21M in proceeds from Vivasure acquisition

HAE

Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics

Jan 12, 2026, 9:00 AM EST - 6 months ago

Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics

HAE

Orchestra BioMed price target raised to $12 from $11 at Barclays

2026-01-09T12:25:37.000Z - 6 months ago

Orchestra BioMed price target raised to $12 from $11 at Barclays

Orchestra BioMed initiated with a Buy at TD Cowen

2025-12-10T11:05:22.000Z - 7 months ago

Orchestra BioMed initiated with a Buy at TD Cowen

Orchestra BioMed Announces AVIM Therapy and Virtue SAB Program Presentations at ICI Meeting

Dec 8, 2025, 7:00 AM EST - 7 months ago

Orchestra BioMed Announces AVIM Therapy and Virtue SAB Program Presentations at ICI Meeting

Orchestra BioMed Holdings Transcript: Piper Sandler 37th Annual Healthcare Conference

Dec 3, 2025, 11:00 AM EST - 7 months ago

Orchestra BioMed Holdings Transcript: Piper Sandler 37th Annual Healthcare Conference

Orchestra BioMed Holdings Transcript: Status Update

Nov 12, 2025, 8:00 AM EST - 8 months ago

Orchestra BioMed Holdings Transcript: Status Update

Orchestra BioMed price target lowered to $11 from $12 at Barclays

2025-11-12T10:10:12.000Z - 8 months ago

Orchestra BioMed price target lowered to $11 from $12 at Barclays

Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates

Nov 10, 2025, 4:10 PM EST - 8 months ago

Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates

Orchestra BioMed Holdings Earnings release: Q3 2025

Nov 10, 2025, 7:00 AM EST - 8 months ago

Orchestra BioMed Holdings Earnings release: Q3 2025

Orchestra BioMed Holdings Quarterly report: Q3 2025

Nov 10, 2025, 7:00 AM EST - 8 months ago

Orchestra BioMed Holdings Quarterly report: Q3 2025

Orchestra BioMed to Host Business Update Call on November 12, 2025

Nov 3, 2025, 8:00 AM EST - 8 months ago

Orchestra BioMed to Host Business Update Call on November 12, 2025

MDT

Orchestra BioMed files to sell 8.03M shares of common stock for holders

2025-10-31T21:05:30.000Z - 8 months ago

Orchestra BioMed files to sell 8.03M shares of common stock for holders

Orchestra BioMed Holdings Registration statement: Registration Filing

Oct 31, 2025, 8:00 AM EDT - 8 months ago

Orchestra BioMed Holdings Registration statement: Registration Filing

Orchestra BioMed, Terumo enter new $30M Virtue SAB agreements

2025-10-28T12:20:59.000Z - 8 months ago

Orchestra BioMed, Terumo enter new $30M Virtue SAB agreements

Orchestra BioMed and Terumo Enter into New $30 Million Virtue SAB Strategic Agreements

Oct 28, 2025, 8:00 AM EDT - 8 months ago

Orchestra BioMed and Terumo Enter into New $30 Million Virtue SAB Strategic Agreements

Orchestra BioMed announces first patient enrollments in Virtue SAB

2025-10-27T13:05:24.000Z - 8 months ago

Orchestra BioMed announces first patient enrollments in Virtue SAB

Orchestra BioMed Announces First Patients Enrolled in Virtue® SAB US Pivotal IDE Coronary Trial

Oct 27, 2025, 9:00 AM EDT - 8 months ago

Orchestra BioMed Announces First Patients Enrolled in Virtue® SAB US Pivotal IDE Coronary Trial

Orchestra BioMed announces data summary supporting AVIM Therapy

2025-10-09T12:15:19.000Z - 9 months ago

Orchestra BioMed announces data summary supporting AVIM Therapy

Orchestra BioMed to Showcase Transformative Potential of AVIM Therapy in Keynote Presentation on Hypertensive Heart Disease at Georgia Innovation Summit

Oct 9, 2025, 8:00 AM EDT - 9 months ago

Orchestra BioMed to Showcase Transformative Potential of AVIM Therapy in Keynote Presentation on Hypertensive Heart Disease at Georgia Innovation Summit

MDT

Orchestra BioMed Presents New AVIM Therapy Clinical Data at HRX Demonstrating Substantial and Sustained Blood Pressure Reductions that are Reproducible Upon Reactivation Following Washout

Sep 4, 2025, 5:00 PM EDT - 10 months ago

Orchestra BioMed Presents New AVIM Therapy Clinical Data at HRX Demonstrating Substantial and Sustained Blood Pressure Reductions that are Reproducible Upon Reactivation Following Washout

Orchestra BioMed Announces Publication of Clinical Data Demonstrating Favorable Blood Pressure and Hemodynamic Effects of AVIM Therapy in JACC: Clinical Electrophysiology

Aug 26, 2025, 7:30 AM EDT - 11 months ago

Orchestra BioMed Announces Publication of Clinical Data Demonstrating Favorable Blood Pressure and Hemodynamic Effects of AVIM Therapy in JACC: Clinical Electrophysiology

Orchestra BioMed Announces Publication of AVIM Therapy Clinical Data in JACC: Advances Demonstrating Potential to Improve Cardiac Function in Patients with Hypertension and Diastolic Dysfunction

Aug 14, 2025, 8:00 AM EDT - 11 months ago

Orchestra BioMed Announces Publication of AVIM Therapy Clinical Data in JACC: Advances Demonstrating Potential to Improve Cardiac Function in Patients with Hypertension and Diastolic Dysfunction

Orchestra BioMed Holdings Earnings release: Q2 2025

Aug 12, 2025, 4:00 PM EDT - 11 months ago

Orchestra BioMed Holdings Earnings release: Q2 2025

Orchestra BioMed Holdings Quarterly report: Q2 2025

Aug 12, 2025, 4:00 PM EDT - 11 months ago

Orchestra BioMed Holdings Quarterly report: Q2 2025

Orchestra BioMed Reports Second Quarter 2025 Financial Results and Highlights Recent Business Updates

Aug 12, 2025, 8:14 AM EDT - 11 months ago

Orchestra BioMed Reports Second Quarter 2025 Financial Results and Highlights Recent Business Updates

Orchestra BioMed Announces Rollout of FDA-Approved BACKBEAT Global Pivotal Study Protocol Update Significantly Expanding Patient Eligibility

Aug 8, 2025, 7:00 AM EDT - 11 months ago

Orchestra BioMed Announces Rollout of FDA-Approved BACKBEAT Global Pivotal Study Protocol Update Significantly Expanding Patient Eligibility

Orchestra BioMed Secures Over $111 Million in Proceeds and Committed Capital Following Completion of Strategic Transactions and Concurrent Public and Private Equity Offerings

Aug 5, 2025, 7:00 AM EDT - 11 months ago

Orchestra BioMed Secures Over $111 Million in Proceeds and Committed Capital Following Completion of Strategic Transactions and Concurrent Public and Private Equity Offerings

Orchestra BioMed Announces Pricing of $40 Million Public Offering

Aug 1, 2025, 7:59 AM EDT - 1 year ago

Orchestra BioMed Announces Pricing of $40 Million Public Offering

Orchestra BioMed Announces Proposed Public Offering

Jul 31, 2025, 4:02 PM EDT - 1 year ago

Orchestra BioMed Announces Proposed Public Offering

Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed

Jul 31, 2025, 4:01 PM EDT - 1 year ago

Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed

LGND MDT

Orchestra BioMed Showcases AVIM Therapy as Purpose-Built Solution for Hypertensive Heart Disease at CSI Frankfurt 2025

Jun 18, 2025, 9:30 AM EDT - 1 year ago

Orchestra BioMed Showcases AVIM Therapy as Purpose-Built Solution for Hypertensive Heart Disease at CSI Frankfurt 2025

Orchestra BioMed Holdings Transcript: The Jefferies Global Healthcare Conference 2025

Jun 5, 2025, 3:45 PM EDT - 1 year ago

Orchestra BioMed Holdings Transcript: The Jefferies Global Healthcare Conference 2025

Orchestra BioMed Holdings Transcript: Sidoti May Micro-Cap Virtual Conference

May 22, 2025, 11:30 AM EDT - 1 year ago

Orchestra BioMed Holdings Transcript: Sidoti May Micro-Cap Virtual Conference

Orchestra BioMed Reports First Quarter 2025 Financial Results and Highlights Recent Regulatory and Clinical Milestones

May 12, 2025, 4:28 PM EDT - 1 year ago

Orchestra BioMed Reports First Quarter 2025 Financial Results and Highlights Recent Regulatory and Clinical Milestones

Orchestra BioMed Holdings Earnings release: Q1 2025

May 11, 2025, 6:00 PM EDT - 1 year ago

Orchestra BioMed Holdings Earnings release: Q1 2025

Orchestra BioMed Holdings Quarterly report: Q1 2025

May 11, 2025, 6:00 PM EDT - 1 year ago

Orchestra BioMed Holdings Quarterly report: Q1 2025

Orchestra BioMed's AVIM Therapy Global Intellectual Property Estate Reaches 137 Issued Patents for the Treatment of Hypertension and Heart Failure

May 7, 2025, 8:30 AM EDT - 1 year ago

Orchestra BioMed's AVIM Therapy Global Intellectual Property Estate Reaches 137 Issued Patents for the Treatment of Hypertension and Heart Failure

Orchestra BioMed Holdings Proxy statement: Proxy Filing

Apr 30, 2025, 8:00 AM EDT - 1 year ago

Orchestra BioMed Holdings Proxy statement: Proxy Filing

Orchestra BioMed Holdings Proxy statement: Proxy Filing

Apr 30, 2025, 8:00 AM EDT - 1 year ago

Orchestra BioMed Holdings Proxy statement: Proxy Filing

Orchestra BioMed Holdings Transcript: Chardan Capital’s Trending Issues in Drug Development Conference

Apr 29, 2025, 10:30 AM EDT - 1 year ago

Orchestra BioMed Holdings Transcript: Chardan Capital’s Trending Issues in Drug Development Conference

Orchestra BioMed Receives FDA Approval of IDE to Initiate U.S. Coronary Pivotal Trial Randomizing First-in-Class Sirolimus-AngioInfusion Balloon, Virtue SAB, Head-to-Head with Paclitaxel-Coated Balloon

Apr 29, 2025, 9:00 AM EDT - 1 year ago

Orchestra BioMed Receives FDA Approval of IDE to Initiate U.S. Coronary Pivotal Trial Randomizing First-in-Class Sirolimus-AngioInfusion Balloon, Virtue SAB, Head-to-Head with Paclitaxel-Coated Balloon

Orchestra BioMed Announces AVIM Therapy-Focused Satellite Symposium at HRS 2025 Annual Meeting

Apr 23, 2025, 9:00 AM EDT - 1 year ago

Orchestra BioMed Announces AVIM Therapy-Focused Satellite Symposium at HRS 2025 Annual Meeting

MDT

Orchestra BioMed Receives FDA Breakthrough Device Designation for AVIM Therapy

Apr 22, 2025, 7:00 AM EDT - 1 year ago

Orchestra BioMed Receives FDA Breakthrough Device Designation for AVIM Therapy

Orchestra BioMed Reports Full Year 2024 Financial Results and Provides a Fourth Quarter Business Update

Mar 31, 2025, 4:21 PM EDT - 1 year ago

Orchestra BioMed Reports Full Year 2024 Financial Results and Provides a Fourth Quarter Business Update

Orchestra BioMed Holdings Annual report: Q4 2024

Mar 30, 2025, 6:00 PM EDT - 1 year ago

Orchestra BioMed Holdings Annual report: Q4 2024

Orchestra BioMed Holdings Transcript: TD Cowen 45th Annual Healthcare Conference

Mar 3, 2025, 2:30 PM EST - 1 year ago

Orchestra BioMed Holdings Transcript: TD Cowen 45th Annual Healthcare Conference

Orchestra BioMed to Present at Upcoming Investor Conferences

Feb 20, 2025, 8:00 AM EST - 1 year ago

Orchestra BioMed to Present at Upcoming Investor Conferences

Orchestra BioMed Appoints Vivek Reddy, M.D. as Executive Chairman of the BACKBEAT Study Steering Committee and Chairman of Bioelectronic Therapies Scientific Advisory Board

Feb 18, 2025, 8:00 AM EST - 1 year ago

Orchestra BioMed Appoints Vivek Reddy, M.D. as Executive Chairman of the BACKBEAT Study Steering Committee and Chairman of Bioelectronic Therapies Scientific Advisory Board

Orchestra BioMed Announces Data Demonstrating Favorable Impact of AVIM Therapy on Diastolic Dysfunction, a Key Driver of Heart Failure Progression, will be Presented as Late-Breaking Science at the THT 2025 Conference

Feb 12, 2025, 10:43 AM EST - 1 year ago

Orchestra BioMed Announces Data Demonstrating Favorable Impact of AVIM Therapy on Diastolic Dysfunction, a Key Driver of Heart Failure Progression, will be Presented as Late-Breaking Science at the THT 2025 Conference

Orchestra BioMed Announces Appointment of Former Medtronic SVP of Corporate Development Christopher Cleary to Board of Directors

Feb 5, 2025, 8:00 AM EST - 1 year ago

Orchestra BioMed Announces Appointment of Former Medtronic SVP of Corporate Development Christopher Cleary to Board of Directors

Orchestra BioMed Holdings Transcript: Piper Sandler 36th Annual Healthcare Conference

Dec 4, 2024, 3:00 PM EST - 1 year ago

Orchestra BioMed Holdings Transcript: Piper Sandler 36th Annual Healthcare Conference

Orchestra BioMed to Participate in the Piper Sandler 36th Annual Healthcare Conference

Nov 26, 2024, 4:05 PM EST - 1 year ago

Orchestra BioMed to Participate in the Piper Sandler 36th Annual Healthcare Conference

Orchestra BioMed Holdings Transcript: Jefferies London Healthcare Conference 2024

Nov 19, 2024, 8:00 AM EST - 1 year ago

Orchestra BioMed Holdings Transcript: Jefferies London Healthcare Conference 2024

Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update

Nov 12, 2024, 4:12 PM EST - 1 year ago

Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update

Orchestra BioMed Holdings Earnings release: Q3 2024

Nov 12, 2024, 4:00 PM EST - 1 year ago

Orchestra BioMed Holdings Earnings release: Q3 2024

Orchestra BioMed Holdings Quarterly report: Q3 2024

Nov 12, 2024, 4:00 PM EST - 1 year ago

Orchestra BioMed Holdings Quarterly report: Q3 2024

Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update

Aug 12, 2024, 4:20 PM EDT - 2 years ago

Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update

Orchestra BioMed Holdings Quarterly report: Q2 2024

Aug 12, 2024, 3:00 PM EDT - 2 years ago

Orchestra BioMed Holdings Quarterly report: Q2 2024

Orchestra BioMed Holdings Earnings release: Q2 2024

Aug 12, 2024, 3:00 PM EDT - 2 years ago

Orchestra BioMed Holdings Earnings release: Q2 2024

Orchestra BioMed to Participate in Jefferies Global Healthcare Conference

May 22, 2024, 8:43 AM EDT - 2 years ago

Orchestra BioMed to Participate in Jefferies Global Healthcare Conference

Orchestra BioMed Holdings Slides: Investor Presentation

May 16, 2024, 7:00 AM EDT - 2 years ago

Orchestra BioMed Holdings Slides: Investor Presentation

Orchestra BioMed Holdings Registration statement: Registration Filing

May 15, 2024, 8:00 AM EDT - 2 years ago

Orchestra BioMed Holdings Registration statement: Registration Filing

Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update

May 13, 2024, 4:58 PM EDT - 2 years ago

Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update

Orchestra BioMed Holdings Quarterly report: Q1 2024

May 13, 2024, 7:00 AM EDT - 2 years ago

Orchestra BioMed Holdings Quarterly report: Q1 2024

Orchestra BioMed Holdings Earnings release: Q1 2024

May 13, 2024, 7:00 AM EDT - 2 years ago

Orchestra BioMed Holdings Earnings release: Q1 2024

Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Patents

Apr 30, 2024, 8:30 AM EDT - 2 years ago

Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Patents

Orchestra BioMed Holdings Proxy statement: Proxy Filing

Apr 30, 2024, 8:00 AM EDT - 2 years ago

Orchestra BioMed Holdings Proxy statement: Proxy Filing

Orchestra BioMed Holdings Proxy statement: Proxy Filing

Apr 30, 2024, 8:00 AM EDT - 2 years ago

Orchestra BioMed Holdings Proxy statement: Proxy Filing

Orchestra BioMed Holdings Registration statement: Registration Filing

Apr 25, 2024, 8:00 AM EDT - 2 years ago

Orchestra BioMed Holdings Registration statement: Registration Filing

Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update

Mar 27, 2024, 4:17 PM EDT - 2 years ago

Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update

Orchestra BioMed Holdings Annual report: Q4 2023

Mar 27, 2024, 8:00 AM EDT - 2 years ago

Orchestra BioMed Holdings Annual report: Q4 2023

Orchestra BioMed Holdings Earnings release: Q4 2023

Mar 27, 2024, 8:00 AM EDT - 2 years ago

Orchestra BioMed Holdings Earnings release: Q4 2023

Orchestra BioMed Holdings Registration statement: Registration Filing

Mar 27, 2024, 8:00 AM EDT - 2 years ago

Orchestra BioMed Holdings Registration statement: Registration Filing

Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of Directors

Mar 26, 2024, 8:00 AM EDT - 2 years ago

Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of Directors

Orchestra BioMed to Participate in Upcoming Investor Conferences

Mar 7, 2024, 8:00 AM EST - 2 years ago

Orchestra BioMed to Participate in Upcoming Investor Conferences

Orchestra BioMed Announces Presentation of Results from Clinical Study Demonstrating Favorable Hemodynamic Effects of AVIM Therapy In Hypertensive Pacemaker Patients

Mar 6, 2024, 8:37 AM EST - 2 years ago

Orchestra BioMed Announces Presentation of Results from Clinical Study Demonstrating Favorable Hemodynamic Effects of AVIM Therapy In Hypertensive Pacemaker Patients

Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pacemaker Patients

Jan 8, 2024, 7:30 AM EST - 2 years ago

Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pacemaker Patients

JHisai
JHisai Jul. 1 at 10:10 AM
$OBIO monthly
0 · Reply
JHisai
JHisai Jun. 30 at 7:24 PM
$OBIO -9% and yesterdays gains almost gone, now that s.cks
0 · Reply
JHisai
JHisai Jun. 29 at 8:03 PM
$OBIO
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Jun. 29 at 5:15 PM
$OBIO Added so clearly u didn't have to decipher my message. U should have made easy money here 💬
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Jun. 29 at 4:38 PM
$OBIO There it is $4.39 high.. Super day on this overnight swing winner 🥇 🥇
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Jun. 29 at 3:11 PM
$OBIO Adds are beautiful.. Now has to break $4.30 ✅✅
0 · Reply
JHisai
JHisai Jun. 29 at 2:28 PM
$OBIO
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Jun. 29 at 1:39 PM
$OBIO Adds!
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Jun. 29 at 3:52 AM
$OBIO Needs to break $4.24 for a shot at $5.00🚨🚨
0 · Reply
focafoca99
focafoca99 Jun. 23 at 9:02 PM
$OBIO held its 2026 annual meeting, with shareholders electing directors and approving the auditor, ESPP and compensation advisory
0 · Reply
BinaryLogic
BinaryLogic Jun. 20 at 10:10 AM
$MIST $RCKT $ABCL $OBIO $IMRX [Again]
0 · Reply
Sidoti
Sidoti Jun. 18 at 5:56 PM
Orchestra BioMed ($OBIO) Management Team presented today at the Sidoti Small-Cap Virtual Conference. Watch the replay here: http://dlvr.it/TT68wJ
0 · Reply
Sidoti
Sidoti Jun. 9 at 2:27 PM
See these #healthcare management teams present live and submit your questions during Q&A. $OBIO $SBC $TMCI http://dlvr.it/TSy72G All investors are welcome to join free of charge: http://dlvr.it/TSy72H
0 · Reply
mrm321
mrm321 Jun. 4 at 2:27 PM
$OBIO the next 2 years will triple this stock
0 · Reply
BinaryLogic
BinaryLogic May. 29 at 8:43 AM
$MIST $RCKT $ABCL $OBIO $IMRX
0 · Reply
mrm321
mrm321 May. 28 at 5:00 PM
$OBIO it’s truly genius. They drop the price down to 3.90 then it goes to 4.10 and then drops back down to 3.9 and rinse and repeat. They are playing you, so why not just join them? This rinse and repeat literally happens every 72 hours. You can’t lose
0 · Reply
mhaven2020
mhaven2020 May. 22 at 2:23 PM
$OBIO 🤪
0 · Reply
dick_dasterdly
dick_dasterdly May. 22 at 9:43 AM
$OBIO I am really liking it here. I really am. The catalysts are in the chamber..
0 · Reply
mhaven2020
mhaven2020 May. 21 at 2:10 PM
$ELDN day 22 of 25 expected hold time for target of 20%. Target exit around 4.50(+/- 5%). Starting to sizzle! $OBIO day 3.
0 · Reply
ItsAllAboutBeingFirst
ItsAllAboutBeingFirst May. 20 at 11:44 PM
$AIRS $OBIO $RNTX $TOI
0 · Reply
mhaven2020
mhaven2020 May. 18 at 4:32 PM
$OBIO solid
0 · Reply
ItsAllAboutBeingFirst
ItsAllAboutBeingFirst May. 18 at 1:58 PM
$KZIA $AIRS $OBIO $RNTX Were here all week
0 · Reply